Literature DB >> 1909193

Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.

S Miura1, M Yoshioka, S Tanaka, H Serizawa, H Tashiro, H Asakura, M Tsuchiya.   

Abstract

Faecal clearance of alpha 1-antitrypsin was measured in patients with ulcerative colitis and Crohn's disease and compared with disease activity and markers of protein-calorie malnutrition. Patients with active ulcerative colitis and Crohn's disease showed elevated clearance of alpha 1-antitrypsin and clearance declined in most patients with induction of remission. However, even with inactive disease, elevated protein loss persisted in some patients, presumably reflecting residual inflammation in the intestinal mucosa. There was a significant correlation between clearance of alpha 1-antitrypsin and serum levels of retinol-binding protein and transferrin in patients with ulcerative colitis and with retinol-binding protein in patients with Crohn's disease. Clearance of alpha 1-antitrypsin reflects disease activity in inflammatory bowel disease and correlates with serum levels of rapid-turnover proteins such as retinol-binding protein and transferrin, which are markers for the presence of protein-calorie malnutrition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909193     DOI: 10.1111/j.1440-1746.1991.tb01144.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

Review 1.  Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?

Authors:  Hitoshi Asakura; Kenji Suzuki; Terasu Honma
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

2.  Tissue-type plasminogen activator of colonic mucosa in ulcerative colitis. Evidence of endothelium-derived fibrinolytic activation.

Authors:  I Kurose; S Miura; M Suematsu; H Serizawa; D Fukumura; H Asako; T Hibi; M Tsuchiya
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

3.  Successful treatment of protein-losing gastroenteropathy with steroid pulse and immunosuppressive therapies in a patient with sjögren syndrome.

Authors:  Tetsushi Nasu; Kaori Miyata; Akiko Uno; Akira Kawashima; Michi Kondo; Takashi Akamizu; Taisei Nakao
Journal:  Case Rep Gastroenterol       Date:  2011-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.